Skip to main content
. 2021 Mar 11;11(3):498. doi: 10.3390/diagnostics11030498

Table 1.

Patient characteristics.

Characteristics PDAC (n = 36) Non-PDAC (n = 16) Control
TFP (n = 15) NET (n = 1) (n = 33)
Sex (Male/Female) 22/14 10/5 1/0 12/21
Age (year) 68.3 ± 12.2 64.0 ± 10.4 64 68.0 ± 12.4
(35–87) (48–84) - (35-94)
BMI (kg/m2) 21.4 ± 3.19 22.3 ± 3.95 24.6 22.4 ± 2.46
(15.5–28.5) (17.0–31.2) - (18.3-28.3
Smoking, n (%) 18 (50) 6 (40) 0 (0) 12(36.4)
Alcohol, n (%) 4 (11.1) 3 (20) 0 (0) 3(9.1)
Diabetes mellitus, n (%) 8 (22.2) 5 (33.3) 0 (0) 4(12.1)
Pancreatic lesion
Location (Head/Body or Tail) 13/23 8/7 1/0
Size (mm) 28.0 ± 12.3 28.6 ± 8.86 22.0
(13.0–69.6) (14.0–40.0) -
Histological assessment
(FNA/Resection) 23/13 15/0 0/1

PDAC, pancreatic ductal adenocarcinoma; TFP, tumor-forming pancreatitis; NET, neuroendocrine tumor; BMI, body mass index; FNA, fine needle aspiration.